Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

BZ vs RCUS vs DHX vs MAN vs ZM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BZ
Kanzhun Limited

Staffing & Employment Services

IndustrialsNASDAQ • CN
Market Cap$12.38B
5Y Perf.-64.1%
RCUS
Arcus Biosciences, Inc.

Biotechnology

HealthcareNYSE • US
Market Cap$2.50B
5Y Perf.-9.7%
DHX
DHI Group, Inc.

Staffing & Employment Services

IndustrialsNYSE • US
Market Cap$138M
5Y Perf.-5.6%
MAN
ManpowerGroup Inc.

Staffing & Employment Services

IndustrialsNYSE • US
Market Cap$1.41B
5Y Perf.-74.4%
ZM
Zoom Communications, Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$33.30B
5Y Perf.-72.0%

BZ vs RCUS vs DHX vs MAN vs ZM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BZ logoBZ
RCUS logoRCUS
DHX logoDHX
MAN logoMAN
ZM logoZM
IndustryStaffing & Employment ServicesBiotechnologyStaffing & Employment ServicesStaffing & Employment ServicesSoftware - Application
Market Cap$12.38B$2.50B$138M$1.41B$33.30B
Revenue (TTM)$8.01B$236M$125M$17.96B$4.87B
Net Income (TTM)$2.49B$-369M$-2M$-13M$1.90B
Gross Margin84.5%90.7%84.8%16.7%77.0%
Operating Margin26.9%-168.6%0.5%0.8%23.1%
Forward P/E1.7x25.0x8.3x18.4x
Total Debt$302M$99M$47M$2.39B$31M
Cash & Equiv.$2.55B$222M$3M$871M$1.27B

BZ vs RCUS vs DHX vs MAN vs ZMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BZ
RCUS
DHX
MAN
ZM
StockJun 21May 26Return
Kanzhun Limited (BZ)10035.9-64.1%
Arcus Biosciences, … (RCUS)10090.3-9.7%
DHI Group, Inc. (DHX)10094.4-5.6%
ManpowerGroup Inc. (MAN)10025.6-74.4%
Zoom Communications… (ZM)10028.0-72.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: BZ vs RCUS vs DHX vs MAN vs ZM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ZM leads in 3 of 7 categories (5-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Kanzhun Limited is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. RCUS and MAN also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
BZ
Kanzhun Limited
The Income Pick

BZ is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • Dividend streak 1 yrs, beta 1.22
  • Rev growth 23.6%, EPS growth 43.9%, 3Y rev CAGR 20.0%
  • 23.6% revenue growth vs DHX's -9.9%
  • Lower P/E (1.7x vs 18.4x)
Best for: income & stability and growth exposure
RCUS
Arcus Biosciences, Inc.
The Long-Run Compounder

RCUS ranks third and is worth considering specifically for long-term compounding.

  • 45.9% 10Y total return vs ZM's 74.8%
  • +209.6% vs MAN's -17.0%
Best for: long-term compounding
DHX
DHI Group, Inc.
The Industrials Pick

Among these 5 stocks, DHX doesn't own a clear edge in any measured category.

Best for: industrials exposure
MAN
ManpowerGroup Inc.
The Income Pick

MAN is the clearest fit if your priority is dividends.

  • 4.7% yield; the other 4 pay no meaningful dividend
Best for: dividends
ZM
Zoom Communications, Inc.
The Defensive Pick

ZM carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.

  • Lower volatility, beta 0.95, Low D/E 0.3%, current ratio 4.33x
  • Beta 0.95, current ratio 4.33x
  • 39.0% margin vs RCUS's -156.4%
  • Beta 0.95 vs RCUS's 1.95, lower leverage
Best for: sleep-well-at-night and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthBZ logoBZ23.6% revenue growth vs DHX's -9.9%
ValueBZ logoBZLower P/E (1.7x vs 18.4x)
Quality / MarginsZM logoZM39.0% margin vs RCUS's -156.4%
Stability / SafetyZM logoZMBeta 0.95 vs RCUS's 1.95, lower leverage
DividendsMAN logoMAN4.7% yield; the other 4 pay no meaningful dividend
Momentum (1Y)RCUS logoRCUS+209.6% vs MAN's -17.0%
Efficiency (ROA)ZM logoZM15.9% ROA vs RCUS's -35.3%, ROIC 10.4% vs -64.1%

BZ vs RCUS vs DHX vs MAN vs ZM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BZKanzhun Limited
FY 2024
Online Recruitment Services To Enterprises Customers
98.8%$7.3B
Others
1.2%$86M
RCUSArcus Biosciences, Inc.
FY 2025
License And Development Services
87.4%$221M
Development Services
6.7%$17M
R&D Services
3.2%$8M
License
2.8%$7M
DHXDHI Group, Inc.
FY 2024
Tech-Focused
100.0%$142M
MANManpowerGroup Inc.
FY 2024
StaffingandInterim
87.5%$15.7B
Outcome-BasedSolutionsandConsulting
7.0%$1.3B
PermanentRecruitment
2.7%$492M
Other
2.7%$482M
Franchise
0.1%$14M
ZMZoom Communications, Inc.
FY 2025
Reportable Segment
100.0%$4.7B

BZ vs RCUS vs DHX vs MAN vs ZM — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLZMLAGGINGDHX

Income & Cash Flow (Last 12 Months)

BZ leads this category, winning 3 of 6 comparable metrics.

MAN is the larger business by revenue, generating $18.0B annually — 143.4x DHX's $125M. ZM is the more profitable business, keeping 39.0% of every revenue dollar as net income compared to RCUS's -156.4%. On growth, BZ holds the edge at +13.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBZ logoBZKanzhun LimitedRCUS logoRCUSArcus Biosciences…DHX logoDHXDHI Group, Inc.MAN logoMANManpowerGroup Inc.ZM logoZMZoom Communicatio…
RevenueTrailing 12 months$8.0B$236M$125M$18.0B$4.9B
EBITDAEarnings before interest/tax$2.2B-$391M$11M$236M$1.3B
Net IncomeAfter-tax profit$2.5B-$369M-$2M-$13M$1.9B
Free Cash FlowCash after capex$3.3B-$489M$20M-$161M$1.9B
Gross MarginGross profit ÷ Revenue+84.5%+90.7%+84.8%+16.7%+77.0%
Operating MarginEBIT ÷ Revenue+26.9%-168.6%+0.5%+0.8%+23.1%
Net MarginNet income ÷ Revenue+31.1%-156.4%-1.8%-0.1%+39.0%
FCF MarginFCF ÷ Revenue+41.5%-2.1%+16.3%-0.9%+39.5%
Rev. Growth (YoY)Latest quarter vs prior year+13.2%-39.3%-8.1%+7.1%+5.3%
EPS Growth (YoY)Latest quarter vs prior year+63.5%+10.5%+119.0%+36.2%+91.4%
BZ leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

MAN leads this category, winning 4 of 6 comparable metrics.

At 17.5x trailing earnings, ZM trades at a 36% valuation discount to BZ's 27.6x P/E. On an enterprise value basis, MAN's 9.0x EV/EBITDA is more attractive than DHX's 56.6x.

MetricBZ logoBZKanzhun LimitedRCUS logoRCUSArcus Biosciences…DHX logoDHXDHI Group, Inc.MAN logoMANManpowerGroup Inc.ZM logoZMZoom Communicatio…
Market CapShares × price$12.4B$2.5B$138M$1.4B$33.3B
Enterprise ValueMkt cap + debt − cash$12.0B$2.4B$181M$2.9B$32.1B
Trailing P/EPrice ÷ TTM EPS27.61x-7.54x-10.63x-104.90x17.53x
Forward P/EPrice ÷ next-FY EPS est.1.67x25.02x8.28x18.44x
PEG RatioP/E ÷ EPS growth rate0.78x
EV / EBITDAEnterprise value multiple44.10x56.64x9.02x25.52x
Price / SalesMarket cap ÷ Revenue11.45x10.11x1.08x0.08x6.84x
Price / BookPrice ÷ Book value/share2.92x4.22x1.51x0.69x3.40x
Price / FCFMarket cap ÷ FCF31.36x9.99x17.31x
MAN leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

ZM leads this category, winning 7 of 9 comparable metrics.

ZM delivers a 19.4% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-69 for RCUS. ZM carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to MAN's 1.16x. On the Piotroski fundamental quality scale (0–9), BZ scores 7/9 vs RCUS's 0/9, reflecting strong financial health.

MetricBZ logoBZKanzhun LimitedRCUS logoRCUSArcus Biosciences…DHX logoDHXDHI Group, Inc.MAN logoMANManpowerGroup Inc.ZM logoZMZoom Communicatio…
ROE (TTM)Return on equity+14.9%-69.0%-2.3%-0.6%+19.4%
ROA (TTM)Return on assets+11.7%-35.3%-1.1%-0.1%+15.9%
ROICReturn on invested capital+7.3%-64.1%-5.9%+5.6%+10.4%
ROCEReturn on capital employed+8.2%-42.1%-7.8%+6.2%+11.8%
Piotroski ScoreFundamental quality 0–970417
Debt / EquityFinancial leverage0.02x0.16x0.49x1.16x0.00x
Net DebtTotal debt minus cash-$2.3B-$123M$44M$1.5B-$1.2B
Cash & Equiv.Liquid assets$2.6B$222M$3M$871M$1.3B
Total DebtShort + long-term debt$302M$99M$47M$2.4B$31M
Interest CoverageEBIT ÷ Interest expense-13.38x0.04x1.98x
ZM leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ZM leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in DHX five years ago would be worth $10,290 today (with dividends reinvested), compared to $3,514 for MAN. Over the past 12 months, RCUS leads with a +209.6% total return vs MAN's -17.0%. The 3-year compound annual growth rate (CAGR) favors ZM at 19.9% vs MAN's -18.8% — a key indicator of consistent wealth creation.

MetricBZ logoBZKanzhun LimitedRCUS logoRCUSArcus Biosciences…DHX logoDHXDHI Group, Inc.MAN logoMANManpowerGroup Inc.ZM logoZMZoom Communicatio…
YTD ReturnYear-to-date-31.9%+6.5%+95.7%+1.2%+30.1%
1-Year ReturnPast 12 months-9.4%+209.6%+134.6%-17.0%+37.8%
3-Year ReturnCumulative with dividends-20.8%+24.9%-6.2%-46.4%+72.2%
5-Year ReturnCumulative with dividends-60.8%-18.6%+2.9%-64.9%-63.3%
10-Year ReturnCumulative with dividends-60.8%+45.9%-55.1%-30.8%+74.8%
CAGR (3Y)Annualised 3-year return-7.5%+7.7%-2.1%-18.8%+19.9%
ZM leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

ZM leads this category, winning 2 of 2 comparable metrics.

ZM is the less volatile stock with a 0.95 beta — it tends to amplify market swings less than RCUS's 1.95 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ZM currently trades 99.0% from its 52-week high vs BZ's 56.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBZ logoBZKanzhun LimitedRCUS logoRCUSArcus Biosciences…DHX logoDHXDHI Group, Inc.MAN logoMANManpowerGroup Inc.ZM logoZMZoom Communicatio…
Beta (5Y)Sensitivity to S&P 5001.22x1.95x1.11x1.03x0.95x
52-Week HighHighest price in past year$25.26$28.72$3.34$47.34$109.50
52-Week LowLowest price in past year$12.85$7.06$1.25$25.15$69.15
% of 52W HighCurrent price vs 52-week peak+56.4%+86.3%+95.5%+64.3%+99.0%
RSI (14)Momentum oscillator 0–10059.360.554.247.171.2
Avg Volume (50D)Average daily shares traded3.7M1.2M251K1.1M4.4M
ZM leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

BZ leads this category, winning 1 of 1 comparable metric.

Analyst consensus: BZ as "Buy", RCUS as "Buy", DHX as "Hold", MAN as "Hold", ZM as "Hold". Consensus price targets imply 96.6% upside for BZ (target: $28) vs -7.2% for ZM (target: $101). MAN is the only dividend payer here at 4.71% yield — a key consideration for income-focused portfolios.

MetricBZ logoBZKanzhun LimitedRCUS logoRCUSArcus Biosciences…DHX logoDHXDHI Group, Inc.MAN logoMANManpowerGroup Inc.ZM logoZMZoom Communicatio…
Analyst RatingConsensus buy/hold/sellBuyBuyHoldHoldHold
Price TargetConsensus 12-month target$28.00$30.00$37.86$100.56
# AnalystsCovering analysts918112948
Dividend YieldAnnual dividend ÷ price+4.7%
Dividend StreakConsecutive years of raises100
Dividend / ShareAnnual DPS$1.43
Buyback YieldShare repurchases ÷ mkt cap+2.0%0.0%+8.2%+2.7%+4.9%
BZ leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ZM leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). BZ leads in 2 (Income & Cash Flow, Analyst Outlook).

Best OverallZoom Communications, Inc. (ZM)Leads 3 of 6 categories
Loading custom metrics...

BZ vs RCUS vs DHX vs MAN vs ZM: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is BZ or RCUS or DHX or MAN or ZM a better buy right now?

For growth investors, Kanzhun Limited (BZ) is the stronger pick with 23.

6% revenue growth year-over-year, versus -9. 9% for DHI Group, Inc. (DHX). Zoom Communications, Inc. (ZM) offers the better valuation at 17. 5x trailing P/E (18. 4x forward), making it the more compelling value choice. Analysts rate Kanzhun Limited (BZ) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BZ or RCUS or DHX or MAN or ZM?

On trailing P/E, Zoom Communications, Inc.

(ZM) is the cheapest at 17. 5x versus Kanzhun Limited at 27. 6x. On forward P/E, Kanzhun Limited is actually cheaper at 1. 7x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — BZ or RCUS or DHX or MAN or ZM?

Over the past 5 years, DHI Group, Inc.

(DHX) delivered a total return of +2. 9%, compared to -64. 9% for ManpowerGroup Inc. (MAN). Over 10 years, the gap is even starker: ZM returned +74. 8% versus BZ's -60. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BZ or RCUS or DHX or MAN or ZM?

By beta (market sensitivity over 5 years), Zoom Communications, Inc.

(ZM) is the lower-risk stock at 0. 95β versus Arcus Biosciences, Inc. 's 1. 95β — meaning RCUS is approximately 105% more volatile than ZM relative to the S&P 500. On balance sheet safety, Zoom Communications, Inc. (ZM) carries a lower debt/equity ratio of 0% versus 116% for ManpowerGroup Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — BZ or RCUS or DHX or MAN or ZM?

By revenue growth (latest reported year), Kanzhun Limited (BZ) is pulling ahead at 23.

6% versus -9. 9% for DHI Group, Inc. (DHX). On earnings-per-share growth, the picture is similar: Zoom Communications, Inc. grew EPS 92. 5% year-over-year, compared to -109. 6% for ManpowerGroup Inc.. Over a 3-year CAGR, RCUS leads at 30. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BZ or RCUS or DHX or MAN or ZM?

Zoom Communications, Inc.

(ZM) is the more profitable company, earning 39. 0% net margin versus -142. 9% for Arcus Biosciences, Inc. — meaning it keeps 39. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ZM leads at 23. 1% versus -156. 3% for RCUS. At the gross margin level — before operating expenses — RCUS leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BZ or RCUS or DHX or MAN or ZM more undervalued right now?

On forward earnings alone, Kanzhun Limited (BZ) trades at 1.

7x forward P/E versus 25. 0x for DHI Group, Inc. — 23. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BZ: 96. 6% to $28. 00.

08

Which pays a better dividend — BZ or RCUS or DHX or MAN or ZM?

In this comparison, MAN (4.

7% yield) pays a dividend. BZ, RCUS, DHX, ZM do not pay a meaningful dividend and should not be held primarily for income.

09

Is BZ or RCUS or DHX or MAN or ZM better for a retirement portfolio?

For long-horizon retirement investors, ManpowerGroup Inc.

(MAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 03), 4. 7% yield). Arcus Biosciences, Inc. (RCUS) carries a higher beta of 1. 95 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MAN: -30. 8%, RCUS: +45. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BZ and RCUS and DHX and MAN and ZM?

These companies operate in different sectors (BZ (Industrials) and RCUS (Healthcare) and DHX (Industrials) and MAN (Industrials) and ZM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BZ is a mid-cap high-growth stock; RCUS is a small-cap quality compounder stock; DHX is a small-cap quality compounder stock; MAN is a small-cap income-oriented stock; ZM is a mid-cap deep-value stock. MAN pays a dividend while BZ, RCUS, DHX, ZM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

BZ

Quality Mega-Cap Compounder

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 18%
Run This Screen
Stocks Like

RCUS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 54%
Run This Screen
Stocks Like

DHX

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
  • Gross Margin > 50%
Run This Screen
Stocks Like

MAN

Income & Dividend Stock

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 1.8%
Run This Screen
Stocks Like

ZM

Quality Mega-Cap Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 23%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BZ and RCUS and DHX and MAN and ZM on the metrics below

Revenue Growth>
%
(BZ: 13.2% · RCUS: -39.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.